ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in ProMIS Neurosciences Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- 0 vs. Q1 2024
- Shares held
- 3.26M
- −120.3K (−3.6%) vs. Q1 2024
- Total value
- $4.90M
- −$1.56M (−24.1%) vs. Q1 2024
- New holders
- 2
- 0 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $84.3M |
| Q1 2026 | 25 | $78.0M |
| Q4 2025 | 9 | $1.80M |
| Q3 2025 | 23 | $4.25M |
| Q2 2025 | 19 | $4.10M |
| Q1 2025 | 17 | $6.49M |
| Q4 2024 | 17 | $9.21M |
| Q3 2024 | 18 | $12.6M |
| Q2 2024 | 16 | $4.90M |
| Q1 2024 | 16 | $6.46M |
| Q4 2023 | 15 | $3.85M |
| Q3 2023 | 14 | $5.61M |
| Q2 2023 | 13 | $723.8K |
| Q1 2023 | 12 | $889.2K |
| Q4 2022 | 13 | $824.5K |
| Q3 2022 | 13 | $1.13M |
| Q2 2022 | 2 | $468.0K |
| Q1 2022 | 2 | $8.00K |
| Q4 2021 | 2 | $9.00K |
| Q3 2021 | 3 | $14.0K |
| Q2 2021 | 3 | $17.0K |
| Q1 2021 | 3 | $17.0K |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding ProMIS Neurosciences Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 3 | $5 | 0.00% | −250−98.8% | Reduced |
| Northwestern Mutual Wealth Management Co | 4 | $6 | 0.00% | −139−97.2% | Reduced |
| Wells Fargo & Company | 20 | $30 | 0.00% | +20 | New |
| TD Waterhouse Canada Inc. | 133 | $202 | 0.00% | +133 | New |
| National Bank of Canada | 333 | $501 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 713 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,666 | $2.50K | 0.00% | 00.0% | Unchanged |
| Sandy Spring Bank | 3,300 | $4.95K | 0.00% | 00.0% | Unchanged |
| Claret Asset Management Corp | 10,830 | $16.0K | 0.00% | 00.0% | Unchanged |
| Fiduciary Trust Co | 20,008 | $30.0K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 26,042 | $39.1K | 0.00% | 00.0% | Unchanged |
| Hara Capital LLC | 29,416 | $44.1K | 0.03% | 00.0% | Unchanged |
| Bank of Montreal | 30,366 | $55.3K | 0.00% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 265,958 | $398.9K | 0.06% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 1,059,582 | $1.59M | 0.95% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,814,213 | $2.72M | 0.44% | −19,834−1.1% | Reduced |
| Northeast Financial Consultants Inc | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −250−100.0% | Sold out |